Align Technology | ALGN - Gross Profit On Sales

Stock Price
158.78
Daily Change
1.53 0.97%
Monthly
-17.16%
Yearly
-14.10%
Q2 Forecast
154.09

Align Technology reported $736.59M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
3M USD 2.46B 398M Mar/2026
Align Technology USD 736.59M 53M Mar/2026
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Bruker USD 379.8M 69.4M Mar/2026
Cardinal Health USD 2.5B 101M Mar/2026
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Cooper Companies USD 695.2M 44.4M Dec/2025
CVS Health USD 15.62B 2.06B Mar/2026
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 427M 16M Mar/2026
Dexcom USD 750.3M 42.4M Mar/2026
Henry Schein USD 1.07B 7M Mar/2026
Idexx Laboratories USD 722.74M 64.62M Mar/2026
Insulet USD 540.8M 27.8M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Masimo USD 250.8M 3.5M Mar/2026
McKesson USD 3.68B 143M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Revvity USD 387.66M 34M Mar/2026
Solventum Corp USD 1.1B 70M Mar/2026
Stryker USD 3.81B 675M Mar/2026
Teleflex USD 307.43M 21K Mar/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Veeva Systems USD 622.47M 7.11M Dec/2025
Waters USD 542M 15.42M Mar/2026
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025
Zoetis USD 1.62B 20M Mar/2026